Latest filing published 25 Mar 2026 for NEPHROS INC, €149k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert R. Banks Jr. appears in our data through filings on Nephros Inc shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 14 August 2023 and the latest from 23 March 2026.
The open-market record is one-sided, with 4 purchases worth €143k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 option exercise.
In size, the median ticket on the buying side is €20k. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month.
Most recently, on 25 March 2026, the filings show an option exercise worth €149k in Nephros Inc. The last insider purchase was made public on 16 May 2024, 891 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations